Having confirmed the preferential tumor accumulation ability of TLIF, we optimized the TLIF-PTT protocol using a DD-Her2/neu orthotopic breast cancer model by varying the tumor temperature elevated by the 808 nm NIR irradiation (figure 2A). This evidence concerns the gene ERBB2 and breast cancer.